# The Human Medicines (Amendment) (Modular Manufacture and Point of Care) Regulations 2025, Regulation 44: Amendment of regulation 41


In regulation 41(c) (application and effect of manufacturing authorisation), before “the premises,” insert “except in the case of an MM investigational medicinal product or a POC investigational medicinal product,”.

---
Source: https://www.legislation.gov.uk/uksi/2025/87/regulation/44 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-modular-manufacture-and-point-of-care-regulations-2025/regulation-44
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

